(HCA) HCA Holdings - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US40412C1018
HCA: Hospitals, Inpatient, Outpatient, Emergency, Behavioral
HCA Healthcare, Inc. is a leading for-profit healthcare provider in the United States, operating over 180 hospitals and numerous outpatient facilities. These include freestanding ambulatory surgery centers, emergency care facilities, urgent care centers, and diagnostic imaging centers. The company offers comprehensive medical services such as inpatient and outpatient care, emergency services, cardiac care, and physical therapy, utilizing advanced technology like electronic health records to enhance patient care.
As one of the largest healthcare providers globally, HCA Healthcare has a strong regional presence and specializes in various care units, including behavioral health. Their commitment to innovation is evident through telemedicine services and other technological advancements, contributing to their reputation in the healthcare industry.
Based on the provided data, the 3-month forecast for HCA Healthcare (NYSE:HCA) indicates a cautious outlook. The stocks current price is slightly below its 20-day SMA but above the 50-day SMA, with the 200-day SMA indicating a potential downtrend. The ATR of 10.77 suggests moderate volatility. Fundamentally, the P/E ratio of 15.87 is reasonable, with a lower forward P/E of 13.95 indicating expected earnings growth. The Market Cap of over $85 billion positions it as a large-cap stock, while the low P/S ratio may signal undervaluation or slower growth.
Additional Sources for HCA Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
HCA Stock Overview
Market Cap in USD | 82,480m |
Sector | Healthcare |
Industry | Medical Care Facilities |
GiC Sub-Industry | Health Care Facilities |
IPO / Inception | 2011-03-10 |
HCA Stock Ratings
Growth Rating | 68.3 |
Fundamental | 49.5 |
Dividend Rating | 52.2 |
Rel. Strength | 8.84 |
Analysts | 4.2/5 |
Fair Price Momentum | 378.65 USD |
Fair Price DCF | 503.40 USD |
HCA Dividends
Dividend Yield 12m | 0.80% |
Yield on Cost 5y | 2.53% |
Annual Growth 5y | 27.94% |
Payout Consistency | 53.8% |
HCA Growth Ratios
Growth Correlation 3m | 48.2% |
Growth Correlation 12m | -10.6% |
Growth Correlation 5y | 90.6% |
CAGR 5y | 26.21% |
CAGR/Max DD 5y | 0.66 |
Sharpe Ratio 12m | 1.22 |
Alpha | 2.40 |
Beta | 0.238 |
Volatility | 32.70% |
Current Volume | 1976.3k |
Average Volume 20d | 1611k |
As of April 25, 2025, the stock is trading at USD 341.41 with a total of 1,976,326 shares traded.
Over the past week, the price has changed by +1.91%, over one month by +2.27%, over three months by +9.30% and over the past year by +7.88%.
Partly, yes. Based on ValueRay Fundamental Analyses, HCA Holdings (NYSE:HCA) is currently (April 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 49.46 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of HCA as of April 2025 is 378.65. This means that HCA is currently undervalued and has a potential upside of +10.91% (Margin of Safety).
HCA Holdings has received a consensus analysts rating of 4.20. Therefor, it is recommend to buy HCA.
- Strong Buy: 15
- Buy: 3
- Hold: 5
- Sell: 1
- Strong Sell: 1
According to ValueRays Forecast Model, HCA HCA Holdings will be worth about 409 in April 2026. The stock is currently trading at 341.41. This means that the stock has a potential upside of +19.78%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 371 | 8.7% |
Analysts Target Price | 392.2 | 14.9% |
ValueRay Target Price | 409 | 19.8% |